Medullary thyroid carcinoma (MTC) and RET proto-oncogene: Mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form

被引:57
作者
Figlioli, Gisella [1 ]
Landi, Stefano [1 ]
Romei, Cristina [2 ]
Elisei, Rossella [2 ]
Gemignani, Federica [1 ]
机构
[1] Univ Pisa, Dept Biol, I-56124 Pisa, Italy
[2] Univ Pisa, Dept Endocrinol, I-56124 Pisa, Italy
关键词
Medullary thyroid carcinoma; RET gene mutations; RET gene polymorphisms; Meta-analysis; ENDOCRINE NEOPLASIA TYPE-2; CODON; 918; MUTATION; GERMLINE-SEQUENCE VARIANTS; TYROSINE KINASE ACTIVATION; TERM-FOLLOW-UP; PROGNOSTIC-FACTORS; MEN; 2A; MULTIVARIATE-ANALYSIS; DISEASE PHENOTYPE; CLINICOPATHOLOGICAL FEATURES;
D O I
10.1016/j.mrrev.2012.09.002
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Medullary thyroid carcinoma (MTC) is an uncommon malignant tumor arising from the calcitonin-producing parafollicular cells (C cells) of thyroid. It accounts for 5-10% of all thyroid cancers, and it mostly occurs as a sporadic entity (sMTC), but a familial pattern (fMTC) is also possible. RET protooncogene germline mutations are crucial for the onset and the progression of fMTC, and the occurrence of single nucleotide polymorphisms could predispose to the sporadic form. In order to clarify the role of this gene in MTC, we carefully reviewed the PubMed database using appropriate terms. First, we summarized current knowledge of the germline RET mutations, mutation spectrum, and prevalence. We then performed a meta-analysis on the available case-control association studies for sMTC. Finally, we carried out in silico predictions of the best associated variants in the attempt to better define their role in the disease. To date, a total of 39 different RET germline mutations have been identified in fMTC families. The most affected codons are 609, 611, 618, 620 (exon 10) and 634 (exon 11), encoding for the extracellular cysteine-rich domain, and codons 768 (exon 13) and 804 (exon 14) of the intracellular tyrosine kinase domain. Six polymorphisms with at least three studies were included in the meta-analysis (A45A [rs1800858], G691S [rs1799939], L769L [rs1800861 I, S836S [rs1800862], S904S [rs1800863], and IVS1-126G>T [rs2565206]). The meta-analysis demonstrated a modest association of sMTC susceptibility with S836S and a strong association with the IVS1-126G>T polymorphism. Besides RET polymorphisms, we also investigated the role of a few other low-penetrance alleles of genes involved in the RET pathway or in xenobiotic metabolism, but none of these were confirmed. Thus, despite the well-known molecular basis of fMTC, the genetic variants of the sporadic form are still poorly understood, and functional analyses are needed to better understand the consequence of such RET variants and to improve our knowledge on the disease. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:36 / 44
页数:9
相关论文
共 50 条
  • [31] Case report: a p.C618S RET proto-oncogene germline mutation in a large Chinese pedigree with familial medullary thyroid carcinoma
    X.-P. Qi
    R.-B. Ying
    J.-M. Ma
    W.-T. Liu
    Z.-F. Du
    J. Fei
    C.-P. Yang
    Q.-Z. Song
    H.-Y. Jin
    Z.-G. Chen
    J.-S. Han
    J.-Q. Wang
    X.-L. Chen
    Y. Zhao
    J.-J. Lu
    X.-N. Zhang
    Familial Cancer, 2012, 11 : 131 - 136
  • [32] RET oncogene mutations in 75 cases of familial medullary thyroid carcinoma in Japan
    Kameyama, K
    Okinaga, H
    Takami, H
    BIOMEDICINE & PHARMACOTHERAPY, 2004, 58 (6-7) : 345 - 347
  • [33] The Relationship of Cytomorphology of Medullary Thyroid Carcinomas between Family Members with the Same RET Proto-Oncogene Mutation
    Chang, Jan-Shun
    Chang, Chin-Feng
    Yang, Wei-Shiung
    Chang, Tien-Chun
    ACTA CYTOLOGICA, 2011, 55 (06) : 556 - 562
  • [34] Medullary and papillary thyroid carcinomas in a patient with a C634Y mutation in the RET proto-oncogene: A case report
    Ding, Yan
    Feng, Jun
    Xu, Xun-hua
    Yao, Jun
    Ying, Rong-Biao
    INDIAN JOURNAL OF CANCER, 2019, 56 (02) : 173 - 175
  • [35] RET Proto-Oncogene Variants in Patients with Medullary Thyroid Carcinoma from the Mediterranean Basin: A Brief Report
    Neocleous, Vassos
    Fanis, Pavlos
    Frangos, Savvas
    Skordis, Nicos
    Phylactou, Leonidas A. A.
    LIFE-BASEL, 2023, 13 (06):
  • [36] New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation
    Jaggard, M. K. J.
    MacRae, C.
    Ifeacho, S.
    Robinson, S.
    Tolley, N. S.
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2009, 123 (07) : 796 - 800
  • [37] Molecular analysis of the rearranged during transfection proto-oncogene in Moroccan patients with medullary thyroid carcinoma
    El Annas, Abdessamad
    Iraqi, Hinde
    Fritez, Nabila
    El Mzibri, Mohammed
    Bakri, Youssef
    Chraibi, Abdelmjid
    Hila, Latifa
    CLINICAL CANCER INVESTIGATION JOURNAL, 2015, 4 (02): : 188 - 198
  • [38] Multiple Endocrine Neoplasia Type 2B with a RET Proto-Oncogene A883F Mutation Displays a More Indolent Form of Medullary Thyroid Carcinoma Compared with a RET M918T Mutation
    Jasim, Sina
    Ying, Anita K.
    Waguespack, Steven G.
    Rich, Thereasa A.
    Grubbs, Elizabeth G.
    Jimenez, Camilo
    Hu, Mimi I.
    Cote, Gilbert
    Habra, Mouhammed Amir
    THYROID, 2011, 21 (02) : 189 - 192
  • [39] Mutation analysis of the c-mos proto-oncogene and the endothelin-B receptor gene in medullary thyroid carcinoma and phaeochromocytoma
    Eng, C
    Foster, KA
    Healey, CS
    Houghton, C
    Gayther, SA
    Mulligan, LM
    Ponder, BAJ
    BRITISH JOURNAL OF CANCER, 1996, 74 (03) : 339 - 341
  • [40] Hirschsprung’s disease and medullary thyroid carcinoma: 15-year experience with molecular genetic screening of the RET proto-oncogene
    Eliska Vaclavikova
    Lucie Kavalcova
    Richard Skaba
    Sarka Dvorakova
    Pavla Macokova
    Blanka Rouskova
    Bela Bendlova
    Pediatric Surgery International, 2012, 28 : 123 - 128